Ask the Professional
> Dr. JonathanTrent at MDA
Dr. JonathanTrent at MDA
Type your message and click Add Comment
It is best to
first but you may post as a guest.
Enter an optional name and contact email address.
GSI asked Jonathan C. Trent, M.D. Ph.D. several questions about the effects of Gleevec treatment on the cells within gastrointestinal stromal tumors. Dr. Trent is an internist and an Assistant Professor of Medicine in the Department of Sarcoma Medical Oncology at M.D. Anderson Cancer Center in Houston, Texas. GIST is one of his main interests in his practice and in his research.
Effects of Imatinib on (Gleevec) on GIST cells